Drug-Like Human Microbial Metabolites Database

Built on data from the Microbial Metabolome Database (MiMeDB), this platform scores compounds against a multi-dimensional drug-likeness algorithm covering physicochemical compliance (Lipinski’s rules), predicted aqueous solubility (LogS), and synthetic accessibility. Metabolites are then stratified into five priority tiers — Tier 1 reserved for preclinical leads with the strongest structural integrity, manufacturability, and absorption profiles for immediate drug discovery.